› $150,000,000 verdict in personal injury case
Johnson & Johnson, the makers of the Ortho Evra (norelgestromin/ethinyl estradiol) birth control patch, has updated the drug’s warning label to include new data on the odds ratio estimates of venous thromboembolism risk in women on Ortho Evra compared to users of oral contraceptives. The new label was approved by the Food and Drug Administration (FDA).
Alisha Gutcher was just 24 years old when she suffered from chest pains and lightheadedness. “My heart was just freaking out,” she said to the Sault Star. “You could see it jumping in my chest.” When she phoned a friend and complained that she couldn’t breathe, her friend took action, driving her to the emergency room where she was immediately admitted. Doctors told her that blood clots had formed in her lungs (pulmonary embolism) and leg (deep vein thrombosis), and she was on the verge of dying. But what would cause an otherwise healthy young woman to become so seriously ill? Doctors confirmed, it was her birth control patch.
